Advertisement

Topics

Series B lands $70mm for Akero

14:40 EST 13 Dec 2018 | Elsevier Business Intelligence

Just six months after its $65mm Series A financing, Akero Therapeutics Inc. has now raised $70mm through a Series B round led...

Original Article: Series B lands $70mm for Akero

NEXT ARTICLE

More From BioPortfolio on "Series B lands $70mm for Akero"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...